M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Hexal founders to pour EUR 500m in biotechnology
21 August 2008 - Ex-owners of German generics producer Hexal AG, Andreas and Thomas Struengmann will invest EUR 500m in the German biotechnological industry, they revealed on 20 August.The Struengmann brothers, who sold Hexal to Swiss drug company Novartis in 2005 for more than EUR 5.6bn, see...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search